Senior Vice President, Global Development, Novo Nordisk A/S
Graduated as an MD from the University of Copenhagen, defended his doctoral thesis at the same university and he later supplemented this with an EMBA.
25 years of experience within the Pharmaceutical Industry at Novo Nordisk and a Danish Biotech company. The last 15 years in senior managerial positions within project management (Development of Victoza® (liraglutide) among others) and clinical development.
From 2008, as Senior Vice President (SVP), Global Development, responsible for Project and Portfolio Management for Development projects and all Clinical Development processes across Novo Nordisk. In the period since 2008 he revised the setup and aligned the global Novo Nordisk clinical, medical and regulatory (CMR) organisation across +55 countries responsible for execution of clinical trials. This optimisation and establishment of global standards lead to substantial improvements in both quality and global trial productivity.